undefined

Allan Sniderman

Cardiologist and professor of medicine at McGill University with longstanding expertise in lipidology and cardiovascular risk assessment; proponent of ApoB measurement for evaluating and guiding lipid-lowering therapy.

The AI-powered Podcast Player

Save insights by tapping your headphones, chat with episodes, discover the best highlights - and more!
App store bannerPlay store banner
Get the app